Fact CheckerSign in

NCT07061691Enrolling by invitation

WIM Exosuit Wearable Soft Robot for Enhancing Walking Activity

Source: ClinicalTrials.gov · Last updated 22 Oct 2026

Brief summary (registry, in English)

This study is to develop, test, and optimize a soft hip wearable robot for individuals with stroke, Parkinson's, multiple sclerosis, or older adults with no neurologic deficits.

Status (registry)
Enrolling by invitation
Study type
Interventional
Enrollment
20 (estimated)
First submitted
27 Jun 2025
Start date
7 Jul 2025
Primary completion date
Jul 2028
Lead sponsor
Shirley Ryan AbilityLab
Diseases
Stroke
NCT number
NCT07061691

What you commit to

  • Study type: Interventional
  • Planned participants: 20
  • From 7 Jul 2025 to the primary completion date, Jul 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • \- \<90 days post major orthopedic surgery (i.e. hip, knee, and/or ankle joint replacement.)

Other illness

  • \< 6 months post CABG or cardiac valve procedure
  • Any skin irritations / conditions that may preclude a participant from tolerating the use of the exosuit.
  • Severe osteoporosis, defined as osteoporosis that has been diagnosed and a participant's doctor has recommended pharmacologic treatment, or there is both a history of osteoporosis and a history of fractures.
  • Serious cardiac conditions, such as hospitalization for myocardial infarction or heart surgery within 3 months, history of congestive heart failure, documented serious and unstable cardiac arrhythmias, hypertrophic cardiomyopathy, severe aortic stenosis, angina or dyspnea at rest or during activities of daily living.
  • Uncontrolled hypertension (resting systolic blood pressure greater than or equal to 150, or resting diastolic pressure greater than or equal to 90.) If a participant demonstrates a BP greater than these values, then the participant will sit quietly for 5 mins, and then be re-checked. If the BP values remain over those thresholds, then the participant will be excluded. Individuals in such situations may return to be re-screened for participation after they follow up with their physician and the hypertension is better controlled.
  • Modified Ashworth Spasticity (MAS) scores of ≥ 3 in hip flexors or extensors, if the participant is post-stroke or multiple sclerosis.
  • Pre-existing neurological disorders such as amyotrophic lateral sclerosis (ALS), dementia
  • History of major head trauma, lower extremity amputation, non-healing ulcers of a lower extremity, ongoing active infections, legal blindness, or a history of significant psychiatric illness.

Other

  • Pregnancy
  • Lower extremity fracture, either currently or within the past 6 months.

Who the study is looking for

  • \- Be at least 6 months post-stroke, have a diagnosis of Parkinson's, have a diagnosis of multiple sclerosis, or an adult older than 65 with no known neurological diagnoses.
    • For the Optimization Aim of the study, Participants may also be healthy individuals with no known impairments.
  • Age: 18-89 years of age
  • For stroke, Parkinson's, multiple sclerosis, or older adult participants, must have adequate cognitive function (MMSE score \>17)
  • Ability to walk at least 10 meters with maximum of 1 person assist
  • Able to safely fit into the WIM exosuit, which is confirmed via an in-person fitting..

Age in the registry: 18 years to 89 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Shirley Ryan AbilityLab
Coordinator of this site? Confirm its status
ChicagoUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.